0001193125-20-148734.txt : 20200521 0001193125-20-148734.hdr.sgml : 20200521 20200521163355 ACCESSION NUMBER: 0001193125-20-148734 CONFORMED SUBMISSION TYPE: 15-15D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200521 DATE AS OF CHANGE: 20200521 EFFECTIVENESS DATE: 20200521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allergan Capital Sarl CENTRAL INDEX KEY: 0001620555 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981114526 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-15D SEC ACT: 1934 Act SEC FILE NUMBER: 333-199019-02 FILM NUMBER: 20902328 BUSINESS ADDRESS: STREET 1: 6, RUE JEAN MONNET CITY: LUXEMBOURG STATE: N4 ZIP: L-2180 BUSINESS PHONE: (862) 261-7000 MAIL ADDRESS: STREET 1: 6, RUE JEAN MONNET CITY: LUXEMBOURG STATE: N4 ZIP: L-2180 FORMER COMPANY: FORMER CONFORMED NAME: Actavis Capital S.a.r.l. DATE OF NAME CHANGE: 20140925 15-15D 1 d918586d1515d.htm 15-15D 15-15D

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Numbers:  333-199019-02

333-223089-03

333-202168-01

 

 

Allergan Capital S.à r.l.

(Exact name of registrant as specified in its charter)

 

 

6, Rue Jean Monnet

L-2180 Luxembourg

Grand Duchy of Luxembourg

+352 2668 3233

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Guarantees of Allergan Funding SCS’s Floating Rate notes due 2020

Guarantees of Allergan Funding SCS’s 0.500% notes due 2021

Guarantees of Allergan Funding SCS’s 3.450% notes due 2022

Guarantees of Allergan Funding SCS’s 1.500% notes due 2023

Guarantees of Allergan Funding SCS’s 1.250% notes due 2024

Guarantees of Allergan Funding SCS’s 3.850% notes due 2024

Guarantees of Allergan Funding SCS’s 3.800% notes due 2025

Guarantees of Allergan Funding SCS’s 2.625% notes due 2028

Guarantees of Allergan Funding SCS’s 2.125% notes due 2029

Guarantees of Allergan Funding SCS’s 4.550% notes due 2035

Guarantees of Allergan Funding SCS’s 4.850% notes due 2044

Guarantees of Allergan Funding SCS’s 4.750% notes due 2045

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

  

☒

Rule 12g-4(a)(2)

  

☐

Rule 12h-3(b)(1)(i)

  

☒

Rule 12h-3(b)(1)(ii)

  

☐

Rule 15d-6

  

☐

Rule 15d-22(b)

  

☐

Approximate number of holders of record as of the certification or notice date:

Guarantees of Allergan Funding SCS’s Floating Rate notes due 2020: Zero (0) holders

Guarantees of Allergan Funding SCS’s 0.500% notes due 2021: Zero (0) holders

Guarantees of Allergan Funding SCS’s 3.450% notes due 2022: Zero (0) holders

Guarantees of Allergan Funding SCS’s 1.500% notes due 2023: Zero (0) holders

Guarantees of Allergan Funding SCS’s 1.250% notes due 2024: Zero (0) holders

Guarantees of Allergan Funding SCS’s 3.850% notes due 2024: Zero (0) holders

Guarantees of Allergan Funding SCS’s 3.800% notes due 2025: Zero (0) holders

Guarantees of Allergan Funding SCS’s 2.625% notes due 2028: Zero (0) holders

Guarantees of Allergan Funding SCS’s 2.125% notes due 2029: Zero (0) holders

Guarantees of Allergan Funding SCS’s 4.550% notes due 2035: Zero (0) holders

Guarantees of Allergan Funding SCS’s 4.850% notes due 2044: Zero (0) holders

Guarantees of Allergan Funding SCS’s 4.750% notes due 2045: Zero (0) holders

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Allergan Capital S.à r.l. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: May 21, 2020     Allergan Capital S.à r.l.
    By:  

/s/ Maurice Mulders

    Name:   Maurice Mulders
    Title:   Class A Manager
    By:  

/s/ Cesar Acosta

    Name:   Cesar Acosta
    Title:   Class B Manager